Page 1 of Clinical Trials for "Carcinoma, Endometrioid", 64 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
Denileukin Diftitox Used in Treating Patients With Advanced Refractory Ovarian Cancer, Primary Peritoneal Carcinoma, or Epithelial Fallopian Tube Cancer
Last Updated: November 15, 2011
Condition(s): Fallopian Tube Cancer; Ovarian Clear Cell Cystadenocarcinoma; Ovarian Endometrioid Adenocarcinoma; Ovarian Mixed Epithelial Carcinoma; Ovarian Mucinous Cystadenocarcinoma; Ovarian Serous Cystadenocarcinoma; Ovarian Undifferentiated Adenocarcinoma; Peritoneal Cavity Cancer; Recurrent Ovarian Epithelial Cancer; Stage III Ovarian Epithelial Cancer; Stage IV Ovarian Epithelial Cancer
2
Completed
Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy
Last Updated: March 28, 2012
Condition(s): Brenner Tumor; Fallopian Tube Cancer; Ovarian Clear Cell Cystadenocarcinoma; Ovarian Endometrioid Adenocarcinoma; Ovarian Mixed Epithelial Carcinoma; Ovarian Mucinous Cystadenocarcinoma; Ovarian Serous Cystadenocarcinoma; Ovarian Undifferentiated Adenocarcinoma; Peritoneal Cavity Cancer; Recurrent Ovarian Epithelial Cancer; Stage III Ovarian Epithelial Cancer; Stage IV Ovarian Epithelial Cancer
3
Not yet recruiting
PTEN and IGFBP-3 Correlation in Ovarian Carcinoma Invasion
Last Updated: September 12, 2005
Condition(s): Ovarian Cancer
4
Completed
Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus
Last Updated: September 16, 2010
Condition(s): Endometrial Cancer
5
Completed
Mifepristone for Patients With Endometrial Cancer and LGESS
Last Updated: March 29, 2010
Condition(s): Endometrial Cancer
6
Recruiting
Beta-Blocker / Ovarian
Last Updated: March 13, 2012
Condition(s): Ovarian Cancer; Primary Peritoneal Carcinoma; Fallopian Tube Cancer
7
Completed
Combination Chemotherapy, Bone Marrow Transplantation, and Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer
Last Updated: April 23, 2011
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
8
Terminated
Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer
Last Updated: January 3, 2012
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
9
Active, not recruiting
Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer
Last Updated: April 19, 2011
Condition(s): Ovarian Cancer; Primary Peritoneal Cavity Cancer
10
Not yet recruiting
Diet and Physical Activity Change or Usual Care in Improving Survival in Patients With Previously Treated Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Last Updated: March 6, 2009
Condition(s): Ovarian Cancer; Peritoneal Cavity Cancer
11
Suspended
A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Last Updated: December 15, 2010
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
12
Recruiting
Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Last Updated: July 20, 2011
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
13
Suspended
Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Last Updated: February 10, 2012
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
14
Completed
Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer
Last Updated: February 6, 2009
Condition(s): Ovarian Cancer
15
Completed
Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial
Last Updated: February 16, 2012
Condition(s): Cancer
16
Suspended
Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Last Updated: April 7, 2012
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
17
Suspended
Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin
Last Updated: November 12, 2010
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
18
Completed
Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer
Last Updated: April 23, 2011
Condition(s): Ovarian Cancer; Primary Peritoneal Cavity Cancer
19
Completed
Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial Cancer
Last Updated: November 6, 2010
Condition(s): Ovarian Cancer
20
Not yet recruiting
Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy
Last Updated: April 17, 2012
Condition(s): Fallopian Tube Cancer; Fatigue; Neuropathy; Neurotoxicity; Ovarian Cancer; Pain; Primary Peritoneal Cavity Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?cond=%22Carcinoma%2C+Endometrioid%22

Page 1 of Clinical Trials for "Carcinoma, Endometrioid", 64 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About